Related references
Note: Only part of the references are listed.A CD44-Targeting Programmable Drug Delivery System for Enhancing and Sensitizing Chemotherapy to Drug-Resistant Cancer
Min Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways
Sheng Yin et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy
Christina H. Eng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin
Yang Wang et al.
AUTOPHAGY (2016)
Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo
Yinan Zhong et al.
BIOMATERIALS (2016)
Polymeric chloroquine as an inhibitor of cancer cell migration and experimental lung metastasis
Fei Yu et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells
M. A. King et al.
ONCOGENE (2016)
Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel
Shan Tang et al.
BIOMATERIALS (2015)
A novel antitumour strategy using bidirectional autophagic vesicles accumulation via initiative induction and the terminal restraint of autophagic flux
Yang Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Chloroquine Targets Pancreatic Cancer Stem Cells via Inhibition of CXCR4 and Hedgehog Signaling
Anamaria Balic et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy
Paola Maycotte et al.
AUTOPHAGY (2012)
Treating metastatic cancer with nanotechnology
Avi Schroeder et al.
NATURE REVIEWS CANCER (2012)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
High Chemokine Receptor CXCR4 Level in Triple Negative Breast Cancer Specimens Predicts Poor Clinical Outcome
Quyen D. Chu et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
L Udabage et al.
EXPERIMENTAL CELL RESEARCH (2005)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine
P Boya et al.
ONCOGENE (2003)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)